Concepedia

Publication | Open Access

Impact of systemic inflammatory markers in patients with <i>ALK</i> -positive non-small cell lung cancer treated with crizotinib

DOIFull Paper Access

13

Citations

32

References

2022

Year

Ozgur Olmez, Pınar Gürsoy, Erdem Çubukçu, Abdullah Sakin, Taner Korkmaz, İbrahim Çil, Burcu Çakar, Serkan Menekşe, Tarık Demir, Jamshid Hamdard
Pulmonology

Abstract

Our findings indicate the prognostic significance of PNI and SII in terms of survival outcome and the impact of mGPS and PNI on treatment response in patients with ALK-positive NSCLC treated with crizotinib.

References

YearCitations

Page 1